•  
  •  
 

Central Asian Problems of Modern Science and Education

Article Title

COGNITIVE IMPAIRMENT IN PATIENTS WITH PARKINSON‘S DISEASE

Abstract

The article presents the data of our studies on cognitive impairment in patients with Parkinson's disease (PD): their characteristics and risk factors, features of clinical manifestations

First Page

125

Last Page

131

References

[1]. Aarsland D., Kurz M.W. // Brain Pathol. – 2010. – Vol. 20. – P. 633–639. [2]. Choi S.H., Jung T.M., Lee J.E. et al. // Neurobiol. of Aging. – 2012. – Vol. 33(7). – P. 1265–1272. [3]. Hughes, A.J. Accuracy of clinical diagnosis of idiopathic Parkinson‘s disease: a clinico-pathological study of 100 cases / A.J. Hughes, S.E. Daniel, L. Kilford, A.J. Lees // J. Neurol. Neurosurg. Psychiatry – 1992. – V. 55. – № 3. – P. 181–184. [4]. Goetz C.G., Poewe W., Rascol O. et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov. Disord. 2004; 19: 1020-1028. [5]. R.C.Peterson.,D.S.Knopmn at al., Mild cognitive impairment : ten years later// Arch Neurol. 2009 Dec. 66(12): 1447-1455 [6]. M.Ikeda., H.Kataoka.,et al. Can levodopa prevent cognitive decline in patients with Parkinson‘s disease // J Neurodegener Dis. 2017; 6(2): 9–14. 131 [7]. Sánchez-Castañeda C, Campdelacreu J, Miró J, Juncadella M, Jaumà S, Calopa M. Cognitive improvement after duodenal levodopa infusion in cognitively impaired Parkinson‘s disease patients. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:250–251.

This document is currently not available here.

Share

COinS